Kanghong pharmaceutical received the regulatory letter: it failed to make the performance forecast before January 31, 2021 as required
Kanghong pharmaceutical announced that the Shenzhen Stock Exchange issued a regulatory letter because the company failed to make a performance forecast before January 31, 2021 as required.
This text is a result of machine translation.
Related companies：
Briefing May 23, 2022 11:54 AM
· Consumer Staples
The Civil Aviation Administration issued a public air transport enterprise business license for Jiangsu Jingdong Cargo Airlines Co., Ltd. (Preparatory)
Briefing Feb 07, 2022 03:40 PM
· Consumer Staples
"Bing dwen dwen" has 29 licensed manufacturers, most of which have access threshold 20 million.
In-depth
Consumer Staples
Unpacking Japanese E-commerce：The Overlooked 120 Million Consumers
Japan is a demanding but high-value market. Chinese sellers are growing fast, yet success requires more than low prices—clear manuals, strong quality, 24/7 service, and trust. Consumption is polarizing, and aging buyers remain active. Long-term branding and localization are key.
Oct 29, 2025 05:24 PM
Jan 30, 2026 06:00 PM
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Briefing Nov 18, 2021 08:39 AM
· Consumer Staples
CSC: the short-term growth of sportswear is under pressure, and the long-term boom continues
Briefing Nov 09, 2021 11:09 AM
· Consumer Staples
The financial technology platform "qiaobidao" received US $150 million in financing
Briefing Sep 23, 2021 01:10 PM
· Consumer Staples
Hong Kong sporting goods stocks continued to decline
Healthcare
Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million
Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.
Jul 16, 2026 02:33 PM
Briefing Sep 02, 2021 03:05 PM
· Consumer Staples
The sports sector of Hong Kong stocks fell, and Li Ning fell nearly 5%
Briefing Aug 09, 2021 09:23 PM
· Automotive
66 times in a month, the policy of new high-rise city continued to increase during the year
Briefing Jul 28, 2021 10:55 AM
· Consumer Staples
Hong Kong sporting goods stocks rose intraday, with Li Ning up more than 11%, Anta Sports up more than 7% and Tebu international up nearly 7%.
Briefing Jul 15, 2021 10:03 AM
· Consumer Staples
Hong Kong Sports Goods stocks were strong, with Tebu international up 6.43%
Briefing Jul 09, 2021 07:30 AM
· Consumer Staples
Since the beginning of this year, the fund has paid dividends of over 120 billion yuan, an increase of 51% compared with the same period last year
See more
Read next
Insight
In-depth
Low-altitude Economy · Interview
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 28, 2026 03:24 PM
Insight
In-depth
Consumer Staples · Analysis
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM